Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.
Kivi
Anatol
A
Trottenberg
Thomas
T
Kupsch
Andreas
A
Plotkin
Michail
M
Felix
Roland
R
Niehaus
Ludwig
L
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000000981:diagnostic imaging* / Q000188:drug therapy; D013378:Substantia Nigra / Q000000981:diagnostic imaging* / Q000473:pathology; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D014326:Tropanes / Q000493:pharmacokinetics
D000978:Antiparkinson Agents; D007457:Iodine Radioisotopes; D014326:Tropanes; C087552:2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane; D007980:Levodopa